IL6 and atherosclerosis: Exogenous IL-6 in the apolipoprotein E-deficient (ApoE−/−) model of atherosclerosis increased the formation of atherosclerotic lesions [57], while the IL-6 receptor antibody downregulated inflammation and reduced atherosclerotic lesion sizes [58].